Frappe ERPNext 16.0.0 before 16.36.0 contains a missing authorization vulnerability in a Manufacturing module endpoint
Source GCVE Database
Not known to be exploited · CVSS 8.3 High : upgrade to 16.36.0 soon.
Data as of 21 Nov 2026, 19:15 UTC
Thin evidence
One scorer or none| CNA (VulnCheck) | CVSS 4.0 | 8.3 |
|---|---|---|
| CNA (VulnCheck) | CVSS 3.1 | 7.7 |
- Patch
- Available – fixed in 16.36.0
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:N/VI:H/VA:N/SC:N/SI:H/SA:NExploitation evidence
Disclosed: evidence found.
CVE published 21 Nov 2026
Detectable: no evidence on record.
No public nuclei template indexed
Weaponized: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 21 Nov 2026.
What to do
Upgrade erpnext and frappe/erpnext to 16.36.0.
Affected software
| Product | Affected | Fixed in |
|---|---|---|
| frappeerpnext | Affected
| Fixed in
|
GitHubfrappe/erpnextpkg:github/frappe/erpnextOther threats | Affected
| Fixed in
|
Check your own hosts for these packages with threat-finder (opens in a new tab), our free open-source scanner.
AI-suggested
A fix is available in Frappe ERPNext version 16.36.0 and later. Users should upgrade to version 16.36.0 or newer to remediate this missing authorization vulnerability. No other mitigation or workaround is indicated.
Description
Frappe ERPNext versions 16.0.0 up to but not including 16.36.0 contain a missing authorization vulnerability in a Manufacturing module endpoint. This flaw allows authenticated users without record-level write permissions to cancel Stock Reservation Entries. Attackers with low privileges can exploit this by sending crafted requests targeting manufacturing documents outside their permitted scope, potentially disrupting stock allocation processes.